心理干预协同药物治疗冠心病伴抑郁焦虑患者60例

Psychological intervention combined with drug therapy in 60 cases of patients with coronary heart disease and anxiety

目的探讨心理干预协同药物治疗在冠心病伴抑郁、焦虑治疗中的作用。方法选择2010年6月～2012年2月冠心病伴抑郁、焦虑的住院患者60例,随机分为干预组和对照组,每组各30例。干预组给予心理干预协同药物治疗,对照组给予单纯药物治疗。两组患者在治疗前和治疗后均采用老年抑郁量表(geriatric depressionscale,GDS)、焦虑自评量表(self-rating anxiety scale,SAS)进行评分,出院时进行临床疗效总体评估。结果治疗后干预组患者的SAS和GAS得分与对照组比较显著降低,差异有统计学意义(P<0.05);干预组治疗后心绞痛发作次数、心脏射血分数(LVEF%)、脑钠肽(BNP)均优于对照组,差异均有统计学意义(均P<0.05);干预组住院天数少于对照组,但差异无统计学意义(P>0.05);干预组总有效率(90.0%)优于对照组(63.3%),差异有统计学意义(P<0.05)。结论对冠心病伴抑郁焦虑患者实施心理干预可以让患者正确面对疾病,提高患者治疗的主动性和积极性,同时可以提高患者生活质量,改善不良情绪,从而提高临床疗效。

Objective To investigate psychological intervention combined with drug therapy in patients with coronary heart disease and anxiety. Methods 60 cases of coronary heart disease combined with anxiety from June 2010 to February 2012 were selected and divided into intervention group and control group randomly with 30 cases in each group. Patients in intervention group were treated with psychological intervention combined with drug therapy, patients in control group were treated with drug therapy only. Geriatric depression scale （GDS） and self-rating anxiety scale （SAS） were used before and after the treatment, clinical curative effect overall evaluation was carried out when patients were discharged. Results GDS and SAS scores in intervention group after the treatment were lower than those in con- trol group, the differences were all statistically significant （all P 〈 0.05）; times of anginal attacks, LVEF%, BNP in in- tervention group after the treatment were all better than those in control group, the differences were all statistically sig- nificant （all P 〈 0.05）; length of stay in intervention group was shorter than that in control group, the difference was not statistically significant （P 〉 0.05）; total effective rate in intervention group （90.0%） was better than that in control group （63.3%）, the difference was statistically significant （P 〈 0.05）. Conclusion Psychological intervention combined with drug therapy for the patients with coronary heart disease and anxiety can let the patients face the disease correct- ly, improve their initiative and enthusiasm, meanwhile, it can improve patients life quality and unhealthy emotions, so it can enhance the clinical curative effects.